Reagent Kits and CassetteS

[¹⁸F]Fluoro-DOPA

Reagent Kits and Cassettes for the automated synthesis of 6-[¹⁸F]Fluoro-L-DOPA

GE TRACERlab® MX
ORA Neptis® (Plug, Perform, RS, DB)
Products
ProductProduct No.QualityProduct sheets (PDF)
Cassette [¹⁸F]Fluoro-DopaPEDP-0062-H

Research Product

Reagent Kit [¹⁸F]Fluoro-DopaPEDP-0062-R

Research Product

Characteristics
  • ABX-developed nucleophilic 3-step synthesis
  • Synthesis time is 95 min
  • Cartridge purification
  • Final volume of Drug Product: 25 ml
  • Final product is designed to conform to Ph. Eur. Monographs
Related products
ProductProduct No.
6-Fluoro-L-DOPA hydrochloride1310
6-Hydroxy-D,L-DOPA1332
n.c.a. Nucleophilic F-L-DOPA precursor1336
Cassette RetainerIND-0021
Ancillary Kit [¹⁸F]Fluoro-DOPAIND-0026
Cassette RetainerIND-0035
GE FASTlab™
GE FASTlab™ 2
Products
ProductProduct No.QualityProduct sheets (PDF)
Cassette [¹⁸F]Fluoro-DopaDP-02-H

GMP Product

Reagent Kit [¹⁸F]Fluoro-DOPADP-102

GMP Product

Characteristics
  • ABX-developed nucleophilic 3-step synthesis
  • Synthesis time is 110 min
  • Cartridge purification
  • Final volume of Drug Product: 28 ml
  • Final product is designed to conform to Ph. Eur. Monographs
Related products
ProductProduct No.
6-Fluoro-L-DOPA hydrochloride1310
6-Hydroxy-D,L-DOPA1332
n.c.a. Nucleophilic F-L-DOPA precursor1336
GE TRACERlab® FX F-N
Synthra®
Products
ProductProduct No.QualityProduct sheets (PDF)
Reagent Kit [¹⁸F]Fluoro-DopaPEDP-0107-R

Research Product

Characteristics
  • ABX-developed nucleophilic 3-step synthesis
  • Cartridge purification
  • Final product is designed to conform to Ph. Eur. Monographs
Related products
ProductProduct No.
6-Fluoro-L-DOPA hydrochloride1310
6-Hydroxy-D,L-DOPA1332
n.c.a. Nucleophilic F-L-DOPA precursor1336
IBA Synthera® (+ and V2)
Products
ProductProduct No.QualityProduct sheets (PDF)
IFP 1 [¹⁸F]Fluoro-DOPAPEDP-0068-H1

Research Product

IFP 2 [¹⁸F]Fluoro-DOPAPEDP-0068-H2

Research Product

Reagent Kit 1 [¹⁸F]Fluoro-DopaPEDP-0068-R1

Research Product

Reagent Kit 2 [¹⁸F]Fluoro-DopaPEDP-0068-R2

Research Product

Characteristics
  • ABX-developed nucleophilic 3-step synthesis
  • Synthesis time is 110 min
  • Cartridge purification
  • Final volume of Drug Product: 30 ml
  • Final product is designed to conform to Ph. Eur. Monographs
Related products
ProductProduct No.
6-Fluoro-L-DOPA hydrochloride1310
6-Hydroxy-D,L-DOPA1332
n.c.a. Nucleophilic F-L-DOPA precursor1336
Product was added